Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
How anesthetic drugs induce and maintain the behavioral state of general anesthesia is an important question in medicine and neuroscience. Different anesthetic drugs act on different molecular targets and neural circuit mechanisms, exhibiting drug-specific EEG features. As a novel ultra-short-acting benzodiazepines drugs, remimazolam has been accepted for induction and maintenance of clinical anesthesia. Compared to the traditional benzodiazepines drugs, remimazolam combines the safety of midazolam with the effectiveness of propofol, and also has the advantages of acting quickly, short half-life, no injection pain, slight respiratory depression, independent of liver and kidney metabolism, long-term infusion without accumulation, and has a specific antagonist: flumazenil. This study aimed to investigate the differences in the characteristics of EEG oscillations during general anesthesia by comparing propofol and remimazolam.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Remimazolam group | Experimental |
|
|
| Propofol group | Active Comparator |
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Remimazolam | Drug | The experimental group was sedated with remimazolam. |
|
| Measure | Description | Time Frame |
|---|---|---|
| EEG waveforms | Contrasting differences in electroencephalographic oscillatory characteristics during general anesthesia with propofol and remimazolam. | Duration from the time the patient enters the operating room to the time they leave the post-anesthesia care unit, average two hours. |
| Measure | Description | Time Frame |
|---|---|---|
| systolic pressure | Indicators related to perioperative hemodynamics | Up to 5 hours including preoperative, intraoperative, and postoperative periods |
| diastolic pressure | Indicators related to perioperative hemodynamics |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Fuzhou Hua, professor | Contact | +8615170238929 | huafuzhou@126.com | |
| Danying Yang, Dr. | Contact | +8615270435219 | yangdanying0315@126.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| the Second Affiliated Hospital of Nanchang University, Nanchang University | Recruiting | Nanchang | Jiangxi | China |
Not provided
Not provided
Not provided
Not provided
Not provided
| Propofol | Drug | The control group was sedated with propofol. |
|
|
| Up to 5 hours including preoperative, intraoperative, and postoperative periods |
| mean pressure | Indicators related to perioperative hemodynamics | Up to 5 hours including preoperative, intraoperative, and postoperative periods |
| heart rate | Indicators related to perioperative hemodynamics | Up to 5 hours including preoperative, intraoperative, and postoperative periods |
| pulse | Indicators related to perioperative hemodynamics | Up to 5 hours including preoperative, intraoperative, and postoperative periods |
| Recovery times | The period from discontinuation of anesthetic drugs to the recovery of the patient's self-consciousness and can respond correctly to external stimuli. All the patients can be allowed to leave the post-anesthesia care unit after Aldrete ≥ 9. Delayed awakening is defined as failure to achieve Aldrete ≥ 9 more than 30 minutes after surgery. | Up to 30 minutes after operation |
| Complication | All the perioperative complications are recorded. | During the perioperative period |
| ID | Term |
|---|---|
| C522201 | remimazolam |
| D017409 | Sufentanil |
| C101584 | cisatracurium |
| D015742 | Propofol |
| ID | Term |
|---|---|
| D005283 | Fentanyl |
| D010880 | Piperidines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D010636 | Phenols |
| D001555 | Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D009930 | Organic Chemicals |
Not provided
Not provided